Clinical features and endoscopic progression of gastroesophageal reflux disease

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 10, 2003, Pages 712-716

  Garrido Serrano, Antonio ^a,b   Guerrero Igea, F J ^a   Lepe Jimenez J A ^a   Perianes Hernandez C ^a  

^a Hospital Comarcal de Riotinto   (Spain)

^b NONE   (Spain)

Author keywords

Endoscopy; Esophagitis; Gastroesophageal reflux; Natural history

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGE; ARTICLE; BARRETT ESOPHAGUS; CLINICAL FEATURE; CONTROLLED STUDY; DIGESTIVE TRACT ENDOSCOPY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DYSPHAGIA; EARLY DIAGNOSIS; ESOPHAGITIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAIN; RELAPSE; SEX DIFFERENCE; SMOKING; STENOSIS;

DISEASE PROGRESSION; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGITIS, PEPTIC; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0345256587     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Eisen G. The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. Am J Gastroenterol 2001; 96: 16-8.
2. Nebel OT, Forner MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-9.
3. Locke GR, Talley NJ, Felt SL, Zinsmeister R, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
4. Alonso PA. PPI test and endoscopy in GERD. Rev Esp Enferm Dig 2002; 94: 88-92.
5. Locke GR. Natural history of nonerosive reflux disease. Is all gastroesophageal reflux disease the same? What is the evidence? Gastroenterol Clin North Am 2002; 31: 59-66.
6. Howard PJ, Maher L, Pryde E, Heading RC. Symptomatic gastro-oesophageal acid exposure and mucosal acid sensitivity are three separates though related aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 128-33.
7. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 24: 7-13.
8. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
9. Savary M, Miller G. L'oesophage. Manual et atlas d'endoscopie. Solothurn: Verlag Gassmann AG 1997.
10. Achem SR. Endoscopy-negative gastroesophageal reflux disease: the hypersensitive esophagus. Gastroenterol Clin North Am 1999; 28: 893-902.
11. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Acid reflux is a poor predictor for severity of erosive reflux esophagitis. Dig Dis Sci 2002; 47: 2565-73.
12. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor M. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999; 13: 59-66.
13. Santolaria S, Quintero E. Tratamiento incial de la ERGE. ¿Empírico o guiado por pruebas? Gastroenterol Hepatol 2001; 24: 38-45.
14. Dust J, Drun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas P, et al. An evidence-based appraisal of reflux disease management. The Genval Workshop Report. Gut 1999; 44 (Supl.): S1-S16.
15. Ellis KK, Ochlke M, Helfand M, Lieberman D. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management? Am J Gastroenterol 1997; 92: 1472-4.
16. Katz PO, Frissora C. The pharmacology and clinical relevance of proton pump inhibitors. Curr Gastroenterol Rep 2002; 4: 459-62.
17. Ashorn M, Ruuska T, Kasikorki R, Laippala P. The natural course of gastroesophageal reflux disease in childhood. Scand J Gastroenterol 2002; 37: 638-41.
18. Manabe N, Yoshihasa M, Saraki A, Tanaka S, Haruma K, Chayama N. Clinical characteristics and natural history of patients with mild grade reflux esophagitis. J Gastroenterol Hepatol 2002; 17: 949-54.
19. Fass R. Gastroesophageal reflux disease revisited. Gastroenterol Clin North Am 2002; 31: 1-10.
20. Sonnenberg A, El-Sarag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999; 72: 81-6.
21. Dunmore F. Care models for the older adult with gastroesophageal reflux disease. Geriatr Nurs 2002; 23: 212-6.
22. Mantynen T, Farkkila M, Kunnama I, Mecklin JP, Juhola M, Voutilainen M. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260.000 inhabitants. Am J Gastroenterol 2002; 97: 2524-9.
23. Spechler SJ. Barret's esophagus. N Engl J Med 2002; 346: 836-42.
24. Morales C, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barret's oesophagus. Lancet 2002; 360: 1587-9.
25. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar lined (Barret's) esophagus: Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-24.
26. Chack A, Lee T, Kinnard MF, Brock W, Faulx A, Willis J, et al. Familial aggregation of Barret's esophagus, oesophageal adenocarcinoma and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002; 51: 323-8.
27. Gerson LB, Triadafilopoulos G. Screening for esophageal adenocarcinoma: an evidence-based approach. Am J Med 2002; 113: 499-505.
28. Velanovich V, Hollingsworth J, Suresh P, Ben-Menachem T. Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia. Dig Surg 2002; 19: 349-35.